Image

Training in Evidence-based Treatments in Psycho-Oncology

Training in Evidence-based Treatments in Psycho-Oncology

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this research study is to train psychotherapists to administer individualized evidence-based psychotherapies in a cancer care setting to participants with elevated levels of distress due to their illness and/or treatment.

The intervention will mirror clinical care in psycho-oncology in which the therapist, collaboratively with their supervisor, will choose specific components of the following evidence-based treatments to administer based on the clinical presentation of the patient and referring problem.

  • Cognitive Behavioral Therapy (CBT)
  • Acceptance Commitment Therapy (ACT)
  • Mindfulness-Based Cognitive Therapy (MBCT)
  • Mindfulness-Based Stress Reduction (MBSR)
  • Meaning-Centered Psychotherapy (MCP)
  • Cognitive Behavioral Therapy for Insomnia (CBT-I)
  • CBT for other cancer-related physical symptoms like pain, fatigue, and nausea.

Participation in this research study is expected to last about 26 weeks.

It is expected that about 100 people and 15 therapists will take part in this research study.

Description

This is a single-arm, behavioral intervention study to train psychotherapists to administer individualized evidence-based psychotherapies in a cancer care setting to participants with elevated levels of distress related to their illness and/or treatment. For participants with cancer, common treatment goals include improving health behaviors, reducing psychological symptoms that may exacerbate medical disability, and/or improving functional status.

Research procedures include screening for eligibility, completion of surveys and questionnaires, and virtual or in-person therapy sessions.

The intervention will mirror clinical care in psycho-oncology in which the therapist, collaboratively with their supervisor, will choose specific components of the following evidence-based treatments to administer based on the clinical presentation of the patient and referring problem.

  • Cognitive Behavioral Therapy (CBT)
  • Acceptance Commitment Therapy (ACT)
  • Mindfulness-Based Cognitive Therapy (MBCT)
  • Mindfulness-Based Stress Reduction (MBSR)
  • Meaning-Centered Psychotherapy (MCP)
  • Cognitive Behavioral Therapy for Insomnia (CBT-I)
  • CBT for other cancer-related physical symptoms like pain, fatigue, and nausea.

Participation in this research study is expected to last about 26 weeks.

It is expected that about 100 people and 15 therapists will take part in this research study.

Patient participants will be those who a) are currently receiving oncology care, including active treatment and/or surveillance, b) report elevated levels of distress (≥ 3 on the NCCN Distress Thermometer), c) report that their distress or presenting concerns are related to their illness and/or their treatment(s), and d) have a clinical presentation that matches an evidence-based treatment (e.g., CBT-I for insomnia/sleep disturbance) for cancer-related distress per the therapist and the supervising therapist's discretion. The investigators aim to recruit up to 100 patient participants to this study over the course of 5 years. Therapist participants will be fellows or residents in the Mass General's Center for Psychiatric Oncology & Behavioral Sciences. The investigators aim to include up to 15 therapist participants over the course of this 5-year study. The study period for therapist participation would be up to 3 years, and would end either at a) 3 years, b) the point at which the therapist obtains licensure and transitions to faculty member, c) the time the therapist leaves MGH.

Eligibility

Patient Inclusion Criteria:

  • Adults > 18 years of age.
  • Currently receiving oncology treatment/care at the MGH Cancer Center, including active treatment and/or surveillance.
  • Reports elevated levels of distress on the National Comprehensive Cancer Network (NCCN) Distress Thermometer > 3.
  • Reports distress or presenting problem is related to patients' illness and/or treatment (e.g., cancer treatment).
  • Has a clinical presentation that matches an evidence-based treatment (e.g., CBT-I for insomnia/sleep disturbance) for cancer-related distress per therapist and supervising therapist discretion.
  • Located in the state of Massachusetts for the duration of sessions.

Patient Exclusion Criteria:

  • Has uncontrolled psychosis, active suicidal ideation, or psychiatric hospitalization within the past year (assessed through EHR review and screening session using the MINI), indicating the need for tailored treatment referral to specialty mental healthcare outside of psycho-oncology or to a higher level of care such as an intensive outpatient program (IOP).
  • Has a cognitive impairment that prohibits participation in the study (assessed through EHR review and screening session).
  • Currently participating in group or individual evidence-based psychotherapy treatment or other psychosocial intervention trial.
  • Has an alcohol or substance dependence (other than nicotine dependence) in the past 8 weeks (assessed through EHR review and screening session using the MINI), indicating the need for tailored treatment referral to specialty mental healthcare outside of psycho-oncology or to a higher level of care such as an intensive outpatient program (IOP).

Therapist Inclusion criteria:

        -Current appointment as a clinical psychology fellow or psychiatry resident at the
        Massachusetts General Hospital or equivalent designation.
        Therapist Exclusion criteria:
        -Obtained licensure as a clinical psychologist in any state.

Study details
    Distress
    Emotional
    Depression
    Anxiety
    Fatigue
    Pain
    Insomnia

NCT05674357

Massachusetts General Hospital

20 February 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.